[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

BAC SWOT Company Research Reports

BAC Reports is market analysis and consulting organisation engaged in creating a myriad of top-level, strategically assessed, elaborate reports each year, tracking various industrial markets on a global basis, region- and country-wide. BAC’s team of experts set heart on helping their diverse transnational customers attain steady growth and sought-for levels of performance in what they are dealing in.

These research reports endeavour to give all-encompassing overviews of different companies’ affairs, sales volumes and lucrative markets they are operating in; define companies’ competitive position by providing in-depth SWOT analyses; concentrate on companies’ financial functioning with respect to profitableness, liquidity ratios, credit worthiness, and capital turnover. The research studies make use of manifold data sources, including companies’ quarterly and annual reports, stock information, professional advice and short-to-long-run forecasts, to equip clients with the freshest, valid and nonpartisan information.

Publications found: 54,093
Sort by:

Alder BioPharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alder BioPharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

ChemoCentryx Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ChemoCentryx Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Fate Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Fate Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Nabriva Therapeutics AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nabriva Therapeutics AG Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Neos Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neos Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

OncoMed Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

OncoMed Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

TG Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

TG Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

ADMA Biologics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ADMA Biologics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Altimmune Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Altimmune Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Chimerix Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Chimerix Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

EyeGate Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

EyeGate Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Tocagen Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tocagen Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Dermira, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Dermira, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

ENDRA Life Sciences Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ENDRA Life Sciences Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Regenxbio Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Regenxbio Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Capricor Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Capricor Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Concert Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Concert Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Novocure Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Novocure Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Syndax Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Syndax Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Aduro Biotech Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aduro Biotech Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Bellicum Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bellicum Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

FibroGen Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

FibroGen Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Ocular Therapeutix Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ocular Therapeutix Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Editas Medicine Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Editas Medicine Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

PLx Pharma Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PLx Pharma Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Agios Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Agios Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Wave Life Sciences Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wave Life Sciences Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Karyopharm Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Karyopharm Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Phibro Animal Health Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Phibro Animal Health Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Ionis Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ionis Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Xenon Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Xenon Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

AnaptysBio Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AnaptysBio Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

ANI Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ANI Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

ProQR Therapeutics NV Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ProQR Therapeutics NV Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Vaxart, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vaxart, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Eagle Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Eagle Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Mediwound Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Mediwound Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Ascendis Pharma AS Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ascendis Pharma AS Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Pulmatrix Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pulmatrix Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Quotient Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Quotient Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Aratana Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aratana Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Cellular Biomedicine Group, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cellular Biomedicine Group, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Cerecor Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cerecor Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Natera Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Natera Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Theravance Biopharma Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Theravance Biopharma Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Blueprint Medicines Corp Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Blueprint Medicines Corp Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

GlycoMimetics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

GlycoMimetics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Millendo Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Millendo Therapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Bioverativ Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bioverativ Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Molecular Templates Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Molecular Templates Inc Fundamental Company Report provides a complete overview of the company’s affairs.

July 2024 50 pages

Filters

Search

Categories

4,856
4,667
3,982
3,557
2,630
2,494
2,453
2,343
2,237
2,193
2,162
2,029
1,850
1,609
1,575
1,401
1,325
1,117
1,104
991
849
834
827
649
648
645
604
521
412
395
277
250
240
207
158
1
1

Publishers

54,093

Regions

10,781
4,124
4,082
3,948
3,939
2,270
2,239
2,034
1,961
1,800
1,146
1,049
1,007
950
785
743
694
634
603
531
481
420
419
402
377
335
316
312
277
277
266
230
225
212
207
205
202
200
190
183
155
154
141
140
133
124
119
107
100
98
97
90
90
89
80
71
65
60
59
55
53
44
43
43
40
39
36
35
34
33
33
30
29
22
21
19
18
18
17
16
16
16
16
15
14
13
12
12
10
9
9
9
8
7
6
6
6
6
6
5
5
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

Price

Date

Pages

Offers